Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019941

« Back to Dashboard

NDA 019941 describes EMLA, which is a drug marketed by Actavis Labs Ut Inc and Astrazeneca and is included in two NDAs. It is available from eleven suppliers. Additional details are available on the EMLA profile page.

The generic ingredient in EMLA is lidocaine; prilocaine. There are twenty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lidocaine; prilocaine profile page.

Summary for 019941

Tradename:	EMLA
Applicant:	Actavis Labs Ut Inc
Ingredient:	lidocaine; prilocaine
Patents:	0
Therapeutic Class:	Anesthetics
Formulation / Manufacturing:	see details

Pharmacology for NDA: 019941

Ingredient-type	Amides
Physiological Effect	Local Anesthesia

Suppliers and Packaging for NDA: 019941

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
EMLA	lidocaine; prilocaine	CREAM;TOPICAL	019941	NDA AUTHORIZED GENERIC	Actavis Pharma, Inc.	0591-2070	N	0591-2070-26
EMLA	lidocaine; prilocaine	CREAM;TOPICAL	019941	NDA AUTHORIZED GENERIC	Actavis Pharma, Inc.	0591-2070	N	0591-2070-30

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CREAM;TOPICAL			Strength	2.5%;2.5%
Approval Date:	Dec 30, 1992	TE:	AB	RLD:	Yes

Expired US Patents for NDA 019941

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Actavis Labs Ut Inc	EMLA	lidocaine; prilocaine	CREAM;TOPICAL	019941-001	Dec 30, 1992	➤ Sign Up	➤ Sign Up
Actavis Labs Ut Inc	EMLA	lidocaine; prilocaine	CREAM;TOPICAL	019941-001	Dec 30, 1992	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.